Design Therapeutics, Inc.DSGNNASDAQ
Loading
SG&A Expense Growth Recovery in ProgressRecovering
Percentile Rank50
3Y CAGR-43.7%
5Y CAGR-37.1%
Year-over-Year Change
Year-over-year SG&A expense growth
3Y CAGR
-43.7%/yr
Annual compound
5Y CAGR
-37.1%/yr
Recent deceleration
Percentile
P50
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2025 | 12.78% |
| 2024 | -14.64% |
| 2023 | 11.31% |
| 2022 | 71.72% |
| 2021 | 342.83% |
| 2020 | 129.41% |
| 2019 | 0.00% |